Case History/ Examination
In late November 2023, a 21-year-old man with the diagnosis of
Pre-B-cell ALL admitted to the hematology department of Omid hospital
affiliated to Isfahan \RL University of Medical Sciences (Isfahan,
Iran) for receiving induction chemotherapy. The chemotherapy regimen was
CALGB 10403. The prophylactic regimen during chemotherapy were
levofloxacin, co-trimuxazole, acyclovir and fluconazole. 5 days after
the end of the course of induction chemotherapy the patient became
febrile (T: 38.5).
He presented fatigue, \RL occasional dry cough, and left pleuritic
chest pain with normal vital signs and physical examination. Oxygen
saturation was 96% while the patient was breathing ambient air.